PlainPharmaWatch

CMS Open Payments · Program Year 2024

Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. reported $1,963,903.18 in payments to 21,199 physicians and teaching hospitals across 21,200 transactions.

See the rankings → How this is sourced
$2.0M
Total payments
21,200
Transactions
21,199
Recipients
−$1.2M
General Payments vs PY2023

Ferring Pharmaceuticals Inc. reported $1,963,903.18 in payments to 21,199 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #450 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $92.64 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Ferring Pharmaceuticals Inc. pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#450
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Ferring Pharmaceuticals Inc.'s CMS-reported General Payments decreased by $1.2M (−37.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: FERRING PHARMACEUTICALS INC.PY2023: FERRING PHARMACEUTICALS INC.PY2024: Ferring Pharmaceuticals Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$3.1MPY2024$2.0M
PY2023
$3,112,048.85
PY2024
$1,953,823.18

How Ferring Pharmaceuticals Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Ferring Pharmaceuticals Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,963,903 Top 23% higher than 77% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Ferring Pharmaceuticals Inc.

Rank #450 of 1,925 companies in CMS Open Payments for 2024 belongs to Ferring Pharmaceuticals Inc., which reported $1,963,903.18 across 21,200 transactions to 21,199 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $92.64 per transaction and $92.64 per recipient.

Of the 7 general-payment categories charted below, "Consulting Fee" is the largest at $711.8K across 177 transactions, 36.2% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 7 types of general payments, Ferring Pharmaceuticals Inc.'s largest category was "Consulting Fee" at $711.8K - 36.2% of the company's reported total.

How Ferring Pharmaceuticals Inc. divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$711.8K2. Food and Beverage$510.9K3. Compensation for Services…$470.1K4. Travel and Lodging$242.4K5. Space Rental or Facility …$12.3K6. Compensation for Faculty …$3.8K7. Education$2.5K
Payment Type Amount Transactions
Consulting Fee $711.8K 177
Food and Beverage $510.9K 19,912
Compensation for Services Other Than Consulting $470.1K 267
Travel and Lodging $242.4K 693
Space Rental or Facility Fees $12.3K 4
Compensation for Faculty or Speaker (Medical Education) $3.8K 5
Education $2.5K 141

Recipient Concentration in General Payments

The five largest recipient relationships account for $431,361.09 (22.1%) of $1,953,823.18 in this company's General Payments records across 10,026 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Ferring Pharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Grannum Sant$232.7KPiyush Agarwal$66.1KMichael Williams$45.4KGautam Jayram$44.3KMonica Pasternak$42.8K
  1. 1

    Grannum Sant

    $232,700.00 across 10 reported transactions

  2. 2

    Piyush Agarwal

    $66,136.69 across 43 reported transactions

  3. 3

    Michael Williams

    $45,431.97 across 31 reported transactions

  4. 4

    Gautam Jayram

    $44,250.91 across 46 reported transactions

  5. 5

    Monica Pasternak

    $42,841.52 across 26 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $92.64. Average per recipient: $92.64.

Total Amount

$1,963,903.18

Avg per Transaction

$92.64

Avg per Recipient

$92.64

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Ferring Pharmaceuticals Inc. Share

0.0%

#450 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Ferring Pharmaceuticals Inc.

Grifols USA, LLC

$2.0M 23,281 recipients

Alimera Sciences, Inc.

$2.0M 3,868 recipients

PolyNovo North America LLC

$2.0M 5,925 recipients

Biohaven Pharmaceutical Holding Company Ltd.

$2.0M 0 recipients

Calliditas Therapeutics US Inc.

$2.0M 12,051 recipients

CooperSurgical, Inc.

$1.9M 9,542 recipients

Frequently Asked Questions

How much did Ferring Pharmaceuticals Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,963,903.18 from Ferring Pharmaceuticals Inc. to physicians and hospitals across 21,200 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Ferring Pharmaceuticals Inc.? ▾
21,199 physicians and teaching hospitals received payments from Ferring Pharmaceuticals Inc. in 2024, averaging $92.64 per recipient.
What types of payments did Ferring Pharmaceuticals Inc. make? ▾
Ferring Pharmaceuticals Inc. made 7 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $711.8K, representing 36.2% of the company's reported total.
How does Ferring Pharmaceuticals Inc. rank among pharmaceutical companies? ▾
By total payment amount, Ferring Pharmaceuticals Inc. sits at #450 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Ferring Pharmaceuticals Inc.? ▾
In 2024, Ferring Pharmaceuticals Inc. averaged $92.64 per transaction across 21,200 transactions to 21,199 recipients.
Where does the payment data for Ferring Pharmaceuticals Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Ferring Pharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.